Related Experiment Videos

How to make medicine work--autocracy or democracy?

¹Department of Infectious Diseases, Addenbrooke's Hospital, Cambridge.

Clinical Medicine (London, England)

|August 27, 2003

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A 5' UTR CCG expansion in TBC1D7 causes oculopharyngodistal myopathy.

medRxiv : the preprint server for health sciences·2026

Miglustat: a first-in-class enzyme stabilizer for cipaglucosidase alfa for the treatment of late-onset Pompe disease.

Therapeutic advances in rare disease·2026

Correction: Cross-sectional validation of the PROMIS-Preference scoring system.

PloS one·2025

Efficacy and safety of avalglucosidase alfa in patients with late-onset Pompe disease after 145 weeks of treatment during the COMET trial.

Journal of neurology·2025

Switching Enzyme Replacement Therapy for Late-Onset Pompe Disease From Alglucosidase Alfa to Cipaglucosidase Alfa Plus Miglustat: Post Hoc Effect Size Analysis of PROPEL.

Muscle & nerve·2025

Real-Time Genomic Surveillance for Enhanced Healthcare Outbreak Detection and Control: Clinical and Economic Impact.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025

See all related articles